PlaquEx Combi contains clopidogrel and acetylsalicylic acid (ASA) and belongs to a group of medicines called antiplatelet medicinal products. It prevents the clumping of the platelets in the blood vessels and reduces the chances of blood clots forming.
PlaquEx Combi is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (ASA). PlaquEx Combi is a fixed-dose combination medicinal product for continuation of therapy in:
– non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention;
– ST segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy.
Subject to medical prescription.
Concentration and pharmaceutical form: 75 mg/75 mg hard capsules